December 11, 2019
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
November 6, 2019
Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera's Clinical Trials Platform, Connect2Med
October 15, 2019
Oncology Pharma Appoints Dr. Vijay Mahant as the Chief Scientific Officer and Chief Operating Officer
October 8, 2019
Oncology Pharma Elects Dr. Stefan Gruenwald (MD, Ph.D.) to its Board of Directors
September 30, 2019
Kalos Therapeutics, Inc., Oncology Pharmaceuticals and NanoSmart Pharmaceuticals, Inc., Combination Therapy Offers the Potential of a Safer and More Effective Approach to a Wide Variety of Cancer Treatments
August 19, 2019
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
July 15, 2019
Oncology Pharma Appoints Stefan Gruenwald (MD. Ph.D) as an Advisor on its Advisory Board
June 17, 2019
SourcingLink.net Announces Corporate Name Change to Oncology Pharma, Inc.